Chimeric HLA antibody receptor T cells for targeted therapy of antibody‐mediated rejection in transplantation

Overview of attention for article published in HLA, July 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#34 of 363)
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 13 X posts from 7 X users, with an upper bound of 18,528 followers.

RT @SCImmunologia: 🍾 Enhorabona @immunoclinicbcn per aquest magnífic treball!!! https://t.co/i8l4nxa1Xy

08 Aug 2023

Reply Repost Favourite

🍾 Enhorabona @immunoclinicbcn per aquest magnífic treball!!! https://t.co/i8l4nxa1Xy

08 Aug 2023

Reply Repost Favourite

(3)..mediante la producción de células T transducidas con un receptor de anticuerpo HLA quimérico (CHAR), facilitando la eliminación específica de las células B que producen DSA."https://t.co/G8qPd6GvCF @hospitalclinic @SEinmunologia @nefrocat @SETrasplant

07 Aug 2023

Reply Repost Favourite

Aquí l'enllaç per poder llegir l'articel publicat: https://t.co/xdILp6MXtj

07 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.